Helicobacter pylori and Epstein–Barr Virus Co-Infection in Gastric Disease: What Is the Correlation with p53 Mutation, Genes Methylation and Microsatellite Instability in a Cohort of Sicilian Population?
暂无分享,去创建一个
S. Vieni | T. Fasciana | Teresa Rea | A. Giammanco | N. Serra | R. Anzalone | G. Capra | N. Scibetta | G. Graceffa
[1] G. Martinelli,et al. Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric Cancer , 2021, Pharmaceuticals.
[2] E. Scarpi,et al. Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis , 2020, Gastric Cancer.
[3] S. Cannella,et al. Helicobacter pylori and Epstein–Barr Virus Infection in Gastric Diseases: Correlation with IL-10 and IL1RN Polymorphism , 2019, Journal of oncology.
[4] B. Taylor,et al. Poor survival after resection of early gastric cancer: extremes of survivorship analysis reveal distinct genomic profile , 2019, The British journal of surgery.
[5] P. Ye,et al. Association Between hMLH1 Promoter Methylation and Risk of Gastric Cancer: A Meta-Analysis , 2018, Front. Physiol..
[6] R. Burbano,et al. The intricate interplay between MSI and polymorphisms of DNA repair enzymes in gastric cancer H.pylori associated , 2017, Mutagenesis.
[7] Tayyab Hamid Malik,et al. Gastric Intestinal Metaplasia: An Intermediate Precancerous Lesion in the Cascade of Gastric Carcinogenesis. , 2017, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.
[8] A. Rustgi,et al. Gastric Cancer Genomics: Advances and Future Directions , 2017, Cellular and molecular gastroenterology and hepatology.
[9] S. Moss. The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer , 2016, Cellular and molecular gastroenterology and hepatology.
[10] B. Luo,et al. Methylation and expression of Epstein-Barr virus latent membrane protein 1, 2A and 2B in EBV-associated gastric carcinomas and cell lines. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[11] Jing-xin Li,et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial , 2015, The Lancet.
[12] Steven J. M. Jones,et al. Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.
[13] V. Georgoulias,et al. Prognostic and predictive significance of MSI in stages II/III colon cancer. , 2014, World journal of gastroenterology.
[14] A. Kaneda,et al. DNA methylation in gastric cancer, related to Helicobacter pylori and Epstein-Barr virus. , 2014, World journal of gastroenterology.
[15] Jeffry D. Sander,et al. CRISPR-Cas systems for editing, regulating and targeting genomes , 2014, Nature Biotechnology.
[16] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[17] G. Capra,et al. Giant cell arteritis associated with chronic active Epstein-Barr virus infection. , 2013, Reumatismo.
[18] Guoxin Zhang,et al. Association between Helicobacter pylori infection and diabetes mellitus: a meta-analysis of observational studies. , 2013, Diabetes research and clinical practice.
[19] Sang Min Park,et al. Association Between Metabolic Syndrome and Helicobacter pylori Infection Diagnosed by Histologic Status and Serological Status , 2012, Journal of clinical gastroenterology.
[20] R. Burbano,et al. Epigenetic mechanisms in gastric cancer. , 2012, Epigenomics.
[21] Bin Tean Teh,et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes , 2012, Nature Genetics.
[22] S. Wessler,et al. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. , 2012, The Journal of clinical investigation.
[23] J. Behravan,et al. Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells , 2012, Molecular and Cellular Biochemistry.
[24] H. Aburatani,et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. , 2011, Cancer research.
[25] Daniela Pistoia,et al. Unusual MRI findings in an immunocompetent patient with EBV encephalitis: a case report , 2011, BMC Medical Imaging.
[26] C. V. Leite,et al. Methylation status of CDH1 gene in samples of gastric mucous from Brazilian patients with chronic gastritis infected by Helicobacter pylori. , 2010, Arquivos de gastroenterologia.
[27] C. V. Leite,et al. Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability. , 2010, World journal of gastroenterology.
[28] A. Gasbarrini,et al. Helicobacters and Extragastric Diseases , 2009, Helicobacter.
[29] C. Hassan,et al. Eradication Therapy for Helicobacter pylori in Patients With Gastric MALT Lymphoma: A Pooled Data Analysis , 2009, The American Journal of Gastroenterology.
[30] Ju-Han Lee,et al. Clinicopathological and molecular characteristics of Epstein–Barr virus‐associated gastric carcinoma: A meta‐analysis , 2009, Journal of gastroenterology and hepatology.
[31] Marcos Antônio Pereira de Lima,et al. H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. , 2008, World journal of gastroenterology.
[32] S. Maeda,et al. Pathogenesis of Helicobacter pylori Infection , 2007, Helicobacter.
[33] H. Aburatani,et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells , 2007, Oncogene.
[34] G. Nardone,et al. Diet, H pylori infection and gastric cancer: evidence and controversies. , 2007, World journal of gastroenterology.
[35] K. Murakami,et al. Expression of mutant type-p53 products in H pylori-associated chronic gastritis. , 2007, World journal of gastroenterology.
[36] L. Leval,et al. Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: A pathological and virological study , 2007, Leukemia & lymphoma.
[37] R. Fulton,et al. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[38] B. Luo,et al. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma. , 2006, World journal of gastroenterology.
[39] M. Nakashima,et al. Epstein-Barr virus-associated gastric carcinoma in Kazakhstan. , 2005, World journal of gastroenterology.
[40] M. Bacchi,et al. Epstein-Barr virus infection and gastric carcinoma in São Paulo State, Brazil. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[41] H. Brenner,et al. Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: recent developments and future implications. , 2003, Microbes and infection.
[42] M. Teh,et al. Study of p53 immunostaining in the gastric epithelium of cagA‐positive and cagA‐negative Helicobacter pylori gastritis , 2002, Cancer.
[43] M. Go. Natural history and epidemiology of Helicobacter pylori infection , 2002, Alimentary pharmacology & therapeutics.
[44] M. Toyota,et al. Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer , 2002, International journal of cancer.
[45] K. Miyazaki,et al. Gastric Diseases Related to Helicobacter pylori and Epstein‐Barr Virus Infection , 1998, Microbiology and immunology.
[46] J. Rüschoff,et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. , 1997, Cancer research.
[47] G. Thomas,et al. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. , 1997, Cancer research.
[48] M. Hummel,et al. Epstein‐Barr virus in tumours , 1996, Histopathology.
[49] J. Herman,et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[50] N. Raab-Traub,et al. Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas , 1994, Journal of virology.
[51] P. Correa,et al. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.
[52] T. Tursz,et al. Alterations of the p53 gene in nasopharyngeal carcinoma , 1992, Journal of virology.
[53] P. Chomet,et al. Cytosine methylation in gene-silencing mechanisms. , 1991, Current opinion in cell biology.
[54] L. Brown. Helicobacter pylori: epidemiology and routes of transmission. , 2000, Epidemiologic reviews.